CORC  > 中国医学科学院 北京协和医学院
Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome
Liu Shuang; Li Chen; Tang Ming-Wei; Xu Wen-Shuai; Chen Ke-Qi; Sui Xin; Tian Xin-Lun; Xu Kai-Feng
2019
卷号132期号:19页码:2378-2379
ISSN号2542-5641
DOI10.1097/CM9.0000000000000441
URL标识查看原文
收录类别PUBMED ; CMA系列
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6335458
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Liu Shuang,Li Chen,Tang Ming-Wei,et al. Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome[J],2019,132(19):2378-2379.
APA Liu Shuang.,Li Chen.,Tang Ming-Wei.,Xu Wen-Shuai.,Chen Ke-Qi.,...&Xu Kai-Feng.(2019).Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome.,132(19),2378-2379.
MLA Liu Shuang,et al."Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome".132.19(2019):2378-2379.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace